title: Comprehensive Medication Reviews in Long-term Care Facilities: History of Process Implementation and 2015 Results.
abstract: BACKGROUND
  Since 2013, Part D sponsors have been required to offer comprehensive medication reviews (CMRs) to all beneficiaries enrolled in their medication therapy management (MTM) programs at least annually, including those in long-term care (LTC) settings. Since that time, MTM providers have found that accessing and completing CMRs with beneficiaries is frequently prohibitively complex, since the process often requires a live, face-to-face interactive interview where the beneficiary resides. However, with the migration of the CMR completion rate from a star ratings display measure to an active measure, coupled with the new CMR completion rate cutpoints for 2016, accessing this population for CMR completion has heightened importance.
  
  
  METHODS
  Our proprietary consultant pharmacist (CP) software was programmed in 2012 to produce a cover letter, medication action plan, and personal medication list per CMS standardized format specifications. Using this system, CPs were trained to perform and document CMRs and the interactive interviews. MTM-eligible Part D beneficiaries, identified by several contracted clients as residing in LTC serviced by Omnicare, were provided CMRs and summaries written in CMS standardized format by CPs. Residents with cognitive impairment were identified using 3 data elements in the Minimum Data Set (MDS).
  
  
  METHODS
  In 2015, 7,935 MTM-eligible beneficiaries were identified as receiving medications from an Omnicare pharmacy. After excluding those who were disenrolled by their prescription drug plans, discharged from the LTC facility, or resided in a LTC facility no longer serviced by Omnicare, 5,593 residents were available for CMR completion. Of these, only 3% refused the CMR offer, and 5,392 CMRs (96%) were completed successfully. Thirty-nine percent of residents had cognitive impairment per MDS assessments; in those instances, CMRs were conducted with someone other than the beneficiary. Based on the CMRs and interactive interviews, 7,527 drug therapy problem recommendations were made to prescribers, about 50% of which resulted in an alteration in therapy, including reductions in polypharmacy and high-risk medications.
  
  
  CONCLUSIONS
  The CMR process and written summary in CMS standardized format works effectively for residents in LTC when performed by CPs in the facility, as evidenced by high completion rates and drug therapy problem identification/resolution. Part D plans should further consider using CPs to conduct CMRs in LTC settings.
  
  
  BACKGROUND
  No outside funding supported this research. All authors are employees of Omnicare, a CVS Health Company, and are stockholders of CVS Health. O'Shea and Zarowitz have received research funding (unrelated to the submitted work) from Acadia, AstraZeneca, and Sunovion. The abstract for this article was presented as a research poster at the Academy of Managed Care and Specialty Pharmacy 2016 Annual Meeting; April 21, 2016; San Francisco, California. Study concept and design were contributed by O'Shea and Zarowitz, along with Erwin. O'Shea collected the data, and data interpretation was performed primarily by O'Shea, along with Zarowitz and Erwin. The manuscript was written by O'Shea, along with Zarowitz, and revised primarily by Zarowitz, along with O'Shea and Erwin.
authors.affiliation: 1 Omnicare, Cincinnati, Ohio.
authors.forename: Terrence E
authors.initials: TE
authors.lastname: O'Shea
authors.affiliation: 1 Omnicare, Cincinnati, Ohio.
authors.forename: Barbara J
authors.initials: BJ
authors.lastname: Zarowitz
authors.affiliation: 1 Omnicare, Cincinnati, Ohio.
authors.forename: W Gary
authors.initials: WG
authors.lastname: Erwin
mesh_terms: D006801:Humans; D008134:Long-Term Care / Q000191:economics / Q000458:organization & administration*; D054524:Medicare Part D / Q000458:organization & administration*; D054539:Medication Therapy Management / Q000191:economics / Q000458:organization & administration*; D010593:Pharmaceutical Services / Q000191:economics / Q000458:organization & administration; D010595:Pharmacists / Q000191:economics; D019338:Polypharmacy; D055553:Prescription Drugs / Q000191:economics / Q000627:therapeutic use; D014481:United States
chemical_list: D055553:Prescription Drugs